Innovative Clinical Research Institute, LLC

Whittier, California 90603-2137

0 studies enrolling now · 5 studies all time

What they study most

Blood Cancer, Breast Cancer, Diffuse Large B Cell Lymphoma, Hematological Malignancy, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasm Metastasis, Non-Hodgkin's B-cell Lymphoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Small Lymphocytic Leukemia, Urinary Bladder Neoplasm

Studies at this site

• Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1) — Running, not enrolling
• A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1) — Stopped early
• Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma — Completed
• A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer — Completed
• Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL — Stopped early